DG News
The use of bimatoprost as a replacement for latanoprost among patients with glaucoma resulted in a significant lowering of intraocular pressure (IOP), without significant increases in adverse side effects, according to a study presented here at the 2010 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO).